NICE MEDICAL TECHNOLOGY GUIDANCE RECOMMENDS URGOSTART TREATMENT RANGE
Recently published NICE guidance recommends the use of UrgoStart on Venous Leg Ulcers and Diabetic Foot Ulcers(1).
UrgoStart dressings are proven to reduce healing time for patients, improving patients' quality of life, and are associated with significant cost savings for the NHS compared to non-interactive dressings.
The role of NICE: improving health and social care through evidence-based guidance
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for driving improvement and excellence in health and social care.
It develops national guidance, standards and information on high-quality health and social care to improve outcomes for clinicians and patients(2).
NICE guidance is based on the best available evidence and developed by independent expert committees
NICE Medical Technology Guidance aims to help the NHS adopt clinically and cost effective technologies quickly.
It is developed by independent committees who review all of the best evidence and expert opinions to turn it into actionable recommendations.
The guidance development process includes the review of:
NICE medical technology guidance 42: UrgoStart for treating diabetic foot ulcers and leg ulcers, https://www.nice.org.uk/guidance/mtg42; accessed August 2019
accessed August 2019